Director: Central Laboratory and
Department of
Clinical Biochemistry
Hadassah University Hospitals
Ein-Karem and Mount Scopus
Tel: 972-2-6776673
Cell: 972-50-7874567
Fax: 972-2-6435778
E-mail: mayer@hadassah.org.il
Michael Mayer was born in Haifa, Israel. Following his army service in the Israel Defense Forces as a computer analyst and programmer, he received his B.Sc. in Biochemistry & Physiology from the Hebrew University of Jerusalem (1965), M.Sc. in Biochemistry from the Israel Institute of Technology (Technion, Haifa, 1967), and D.Sc. in Biochemistry from the Israel Institute of Technology (Technion, Haifa, 1970).
Michael Mayer joined the faculty of the Hebrew University-Hadassah Medical School in Jerusalem in 1970, and was appointed Head of the Department of Clinical Biochemistry at the Mount Scopus Hadassah Hospital in 1976. From 1989 Mayer is also Head of the Department of Clinical Biochemistry at the Ein Karem Hadassah Hospital, and since 1988 he is Professor of Medical Biochemistry at The Hebrew University – Hadassah Medical School.
Mayer was a Visiting Scientist/Visiting Professor at the Roswell Park Memorial Institute, Buffalo, N.Y. (1973-5), Temple University School of Medicine, Philadelphia, PA (1981-2), Finsen Institute, University of Copenhagen Medical School, Copenhagen, Denmark (1987-8), and University of Washington Medical School, Seattle, Washington, (1999-2000).
Michael Mayer is active in research, management, and teaching. He authored more than 120 peer-reviewed scientific publications, mainly in the areas of plasminogen activation and plasmin activity, and clinical laboratory management and informatics.
Mayer is teaching in courses on Clinical and Physiological Biochemistry, Regulation of Metabolic Pathways, Human Metabolism and Nutrition, and Selected Topics in Biochemistry, all at the Faculty of Medicine of the Hebrew University in Jerusalem.
He is a member of the American Association of Clinical Chemistry (AACC), The Israel Biochemical Society (Affiliated to FEBS), Israel Society for Clinical Biochemistry and Laboratory Medicine (affiliated to IFCC), Israel Endocrine Society, and Israel Medical Association.
Some of his past and present professional and academic activities are:
Chair, Committee for Financial Laboratory Management, the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) (1993-1997).
Deputy Director, Hadassah University Hospital, Mount Scopus (1980-1987).
Vice-Chair of the Executive Board, Division of Education and Management (EMD), the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) (1997-2000).
President, Israel Society for Clinical Biochemistry and Laboratory Medicine (1993 -1996).
Chairman, Committee for laboratory administration, Hadassah Medical Organization (1989-1993).
National Board Member, Israel Association for Clinical Biochemistry (1982- ).
Member, Board of Heads of Clinical Departments, Hadassah Medical Organization (1999- )
Member, Ethical Committee, Hadassah Medical Organization (2000 - )
Chairman, Israel National Council of Laboratory Medicine (2002 - )
Michael Mayer is married to Yael (Magid) since 1966 and has three daughters and six grandchildren.
Selected Publications since 1995
S. Shimonovitz, S. Yagel, M. Dushnik, E. Anteby, F. Karmeli, Z. Finci-Yeheskel, E. Y. Adashi, M. Mayer and A. Hurwitz. Interleukin-1 stimulates prostaglandin E2 production by human trophoblast cells from first and third trimesters. J. Clin. Endo. Metabol. 78: 1241-1248, 1995.
M. Mayer. Cost-information in rational decision making. Invited monograph (workshop), XI European Congress of Clinical Chemistry, Tampere, July 2-7, 1995.
M. Mayer. Practical application of cost information in laboratory management. Invited monograph in Colloqia on Cost-effective Management of the Clinical Laboratory, XVI International Congress of Clinical Chemistry, Wembley, London, July 7-12, 1996.
A. Hurvitz, Y. Lavy, Z. Finci-Yeheskel, A. Milwidsky, S. Shimonovitz, S. Yagel, E. Y. Adashi, N. Laufer and M. Mayer. Interleukin-1-mediated stimulation of prostaglandin E production is without effect on plasminogen activator activity in human granulosa lutein cell cultures. J. Clin. Endoc. Metab. 80: 3018-3024, 1995.
A. Hurwitz, Z. Finci-Yeheskel, M. Dushnik, A. Milwidsky, S. Shimonovitz, S. Yagel, EY Adashi and M. Mayer. Interleukin-1-mediated regulation of plasminogen activator activity in pregnant mare serum gonadotropin-primed rat granulosa cells is independent of prostaglandin production. J. Soc. Gynecol. Invest. 2: 691-700, 1995.
A. A-R. Higazi, R. Azziza and M. Mayer. Inhibition of plasminogen activation by triiodothyronine. Thrombosis Research 80: 349-355, 1995.
M. Mayer, R. Heikkinen and T. Ærntoft. Laboratory cost management. J. Inter. Fed. Clin. Chem. 8: 20-21, 1996.
A. Revel, V. Barak, Y. Lavy, E. Anteby, D. Abramov, J. G. Shenker, A. Amit, Z. Finci-Yeheskel, M. Mayer, A. Simon, N. Laufer and A. Hurwitz. Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertility and Sterility 66: 66-71, 1996.
E. Y. Anteby, A. Hurwitz, O. Korach, A. Revel, A. Simon, Z. Finci-Yeheskel, M. Mayer and N. Laufer. Human Follicular nitric oxide pathway: relationship to follicular size, oestradiol concentrations and ovarian blood flow. Human Reproductrion 11: 1947-1951, 1996.
A. Hurwitz, Z. Finci-Yeheskel, A. Milwidsky, S. Yagel, EY Adashi, N. Laufer and M. Mayer. In vitro modulation of plasminogen activator activity, prostaglandin E and nitric oxide production by interleukin-1 in pregnant mare serum gonadotrophin-primed theca-interstitial cells. Human Reproduction 12: 774-779, 1997.
A. Hurwitz, Z. Finci - Yeheskel, S. Yagel, S. Shimonovitz, N. Laufer, E. Y. Adashi and M. Mayer. Interleukin-1b inhibits progesterone accumulation in rat corpora luteal cell cultures in a mechanism dissociated from its effects on nitric oxide and prostaglandin E accumulation. Molec. Cell. Endocrin. 133: 41-48, 1998.
D. Hochner-Zelnickier, C. Greenfeld, Z. Finci-Yeheskel , A. Milwidsky, A. Gutman, D. Goldman-Wohl, S. Yagel, and M. Mayer. Tamoxifen exerts estrogen-agonistic effects on proliferation and plasminogen activation, but not on gelatinase activity, glycogen metabolism and p53 protein expression, in cultures of estrogen-responsive human endometrial adenocarcinoma cells. Molecular Human Reproduction 3: 1019-1027, 1997.
M. Mayer. Laboratory cost control and financial management software. Clin. Chim. Acta 270: 55-64, 1998.
M. Mayer, L. Salpeter. More on the interference of N-acetylcysteine in measurement of acetaminophene (letter to the editor). Clin. Chem. 44: 892-893, 1998.
M. Mayer, I. Wilkinson, R. Heikkinen, T. Ørntoft, E. Magid. Improved laboartory test selection and enhanced perception of test results as tools for cost-effective medicine. Clin. Chem. Lab. Med. 36: 683-690, 1998.
R. Heikkinen, M. Mayer, T. Ørntoft, I. Wilkinson. Field study of laboratory organization and management. Committee for Financial management, Education and Management Division International Federation of Clinical Chemistry and Laboratory Medicine, 1998.
M. Mayer, A. Israeli. Improved clinical use of laboratory data through methods for the selection of tests and for better perception of laboratory results.Harefuah (Hebrew) 137: 54-59, 1999.
M. Mayer. Association of serum bilirubin comcentration with risk of coronary artery disease. Clin. Chem. 46: 1723-1727, 2000.
R. Dresner-Pollak, M. Mayer, D. Hochner-Celnikier. The decrease in serum bone-specific alkaline phosphatase predicts bone mineral density response to hormone replacement therapy in early postmenopausal women. Calcif. Tissue Int. 66: 104-107, 2000.
M. Mayer, D. Chou, T. Eytan. Unit-independent reporting of laboratory test results. Clin. Chem. Lab. Med. 39: 50-52, 2001.
G. Rajs, Z. Finzi-Yeheskel, A. Rajs and M. Mayer. C-Reactive protein concentrations in cerebral spinal fluid in gram-positive and gram-negative bacterial meningitis. Clin Chem 48: 591-592, 2002.
A. Hurwitz, Z. Finci-Yeheskel, A. Milwidsky and M. Mayer. Regulation of cyclooxygenase activity and progesterone production in the rat corpus luteum by inducible nitric oxide synthase. Reproduction 123: 663-669, 2002.
G.Landsberg, V. Shatz, I. Akopnik, Y. Wolf, M. Mayer, Y. Berlatsky, C. Weissman, M. Mossery. Association of cardiac troponin, CK-MB and postoperative ischemia with long-term survival following major vascular surgery. J. Amer. Colleg. Cardiol. 42: 1547-54, 2003.
More in: PubMed